- 专利标题: Targeted modification of rat genome
-
申请号: US16451859申请日: 2019-06-25
-
公开(公告)号: US10975390B2公开(公告)日: 2021-04-13
- 发明人: Jeffrey D. Lee , Alexander O. Mujica , Wojtek Auerbach , Ka-Man Venus Lai , David M. Valenzuela , George D. Yancopoulos
- 申请人: Regeneron Pharmaceuticals, Inc.
- 申请人地址: US NY Tarrytown
- 专利权人: Regeneron Pharmaceuticals, Inc.
- 当前专利权人: Regeneron Pharmaceuticals, Inc.
- 当前专利权人地址: US NY Tarrytown
- 代理机构: Alston & Bird LLP
- 代理商 Elysa Goldberg; Yongjin Choi
- 主分类号: C12N15/85
- IPC分类号: C12N15/85 ; A61D19/04 ; A01K67/027 ; C07K14/715 ; C07K14/775 ; C12N15/90
摘要:
Compositions and methods are provided for modifying a rat genomic locus of interest using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Compositions and methods for generating a genetically modified rat comprising one or more targeted genetic modifications in their germline are also provided. Compositions and methods are provided which comprise a genetically modified rat or rat cell comprising a targeted genetic modification in the rat interleukin-2 receptor gamma locus, the rat ApoE locus, the rat Rag2 locus, the rat Rag1 locus and/or the rat Rag2/Rag1 locus. The various methods and compositions provided herein allows for these modified loci to be transmitted through the germline.
公开/授权文献
- US20190323032A1 TARGETED MODIFICATION OF RAT GENOME 公开/授权日:2019-10-24
信息查询
IPC分类: